Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$242.50 USD

242.50
588,907

-3.18 (-1.29%)

Updated Sep 20, 2024 04:00 PM ET

After-Market: $242.37 -0.13 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Teleflex's (TFX) Arrow EZ-IO Needle Receives FDA Approval

by Zacks Equity Research

Teleflex's (TFX) Arrow EZ-IO Needle is the first and only intraosseous (IO) needle for MR Conditional labelling.

Teleflex's (TFX) Wattson Temporary Pacing Receives FDA Nod

by Zacks Equity Research

Teleflex's (TFX) Wattson Temporary Pacing Guidewire offers dual functionality, allowing both valve delivery and ventricular bipolar pacing during TAVR or BAV treatments.

Teleflex (TFX) Q1 Earnings Top Estimates, 2023 Sales View Up

by Zacks Equity Research

Teleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1.

Teleflex (TFX) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Teleflex (TFX) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 4.04% and 3.51%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

OPKO Health (OPK) delivered earnings and revenue surprises of 71.43% and 26.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Teleflex (TFX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sientra (SIEN) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

Sientra (SIEN) delivered earnings and revenue surprises of -137.50% and 2.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Teleflex (TFX) Urolift Market Expansion Strong, Cost Woe Stays

by Zacks Equity Research

Teleflex (TFX) plans to spend 2023 training surgeons, building its presence in key cities and continuing to engage with the Chinese Urological Society to build acceptance.

Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Down

by Zacks Equity Research

Teleflex (TFX) revenues in Asia rise backed by strong contributions from growth in all geographies.

Teleflex (TFX) Surpasses Q4 Earnings Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 2.33% and 0.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Integra LifeSciences (IART) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Integra (IART) delivered earnings and revenue surprises of 1.08% and 0.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Will Teleflex (TFX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Teleflex (TFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Analyst Blog Highlights Comcast, Aon, Trane Technologies, Huntington Bancshares and Teleflex

by Zacks Equity Research

Comcast, Aon, Trane Technologies, Huntington Bancshares and Teleflex are part of the Zacks top Analyst Blog.

Santanu Roy headshot

Top Analyst Reports for Comcast, Aon & Trane Technologies

by Santanu Roy

Today's Research Daily features new research reports on 16 major stocks, including Comcast Corporation (CMCSA), Aon plc (AON) and Trane Technologies plc (TT).

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

by Zacks Equity Research

Investors are optimistic about Teleflex (TFX) on strong preference for the UroLift system.

Teleflex (TFX) OEM Arm Grows, Supply Issue Persists

by Zacks Equity Research

From a geographic perspective, Teleflex (TFX) is seeing strong results in Asia, which continues to be an important growth driver for Teleflex.

Glaukos (GKOS) Up 0.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Teleflex (TFX) Q3 Earnings Top Estimates, Adjusted EPS View Cut

by Zacks Equity Research

For UroLift, Teleflex (TFX) currently assumes 2022 revenues to be roughly $320 million, down from the prior guidance of $335 million.

Teleflex (TFX) Surpasses Q3 Earnings Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 5.48% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Abiomed (ABMD) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Abiomed (ABMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teleflex (TFX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tactile Systems Technology (TCMD) Moves 6.6% Higher: Will This Strength Last?

by Zacks Equity Research

Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes

by Zacks Equity Research

Teleflex's (TFX) lowered revenue and adjusted EPS outlook for 2022 indicates lackluster performance, which increases investors' concern.